C

Convergence Pharmaceuticals

50 employees

Convergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Clinical Trials
Neuroscience
Pain
Medicinal Chemistry
Pain Biology
Electrophysiology
Medical
Health Care

Date founded

2010

Funding rounds raised

Total raised

$35M

from 2 investors over 2 rounds

C

Convergence Pharmaceuticals raised $35M on October 5, 2010

Investors: New Leaf Venture Partners and Apposite Capital

FAQ